Although both NOF and BFH exhibit variable positivity to CD68, they are strongly positive for factor XIIIa + making this immunohistochemical tool important in differentiating tumors with fibrohistiocytic lineage from xanthoma of bone [3, 11, 15]. Here, F13A1 is linked to xanthoma.